RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actions
about
RING finger protein AO7 supports NF-kappaB-mediated transcription by interacting with the transactivation domain of the p65 subunitTranscriptional repression of human immunodeficiency virus type 1 by AP-4Copy number variation of genes involved in the hepatitis C virus-human interactomeTargeting host factors: A novel rationale for the management of hepatitis C virusMolecular dynamics simulation and experimental verification of the interaction between cyclin T1 and HIV-1 Tat proteinsInhibition of the 53BP2S-mediated apoptosis by nuclear factor kappaB and Bcl-2 family proteins.Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP.Transcription analysis on response of porcine alveolar macrophages to Haemophilus parasuis.TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.Cellular heat shock factor 1 positively regulates human immunodeficiency virus-1 gene expression and replication by two distinct pathways.A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production.New treatments for chronic hepatitis C.Gene therapy progress and prospects: novel gene therapy approaches for AIDS.Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.HSP70 binding protein 1 (HspBP1) suppresses HIV-1 replication by inhibiting NF-κB mediated activation of viral gene expression.Reconstructing the temporal progression of HIV-1 immune response pathways.Sequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome.Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.MicroRNA124 regulate cell growth of prostate cancer cells by targeting iASPP.Induction of OGG1 gene expression by HIV-1 Tat.HCV replication and statin pleotropism: an adjuvant treatment panacea?Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.3-methylcholanthrene activates human immunodeficiency virus type 1 replication via aryl hydrocarbon receptor.AKIP1 enhances NF-kappaB-dependent gene expression by promoting the nuclear retention and phosphorylation of p65.Quantitative shotgun proteomics distinguishes wound-healing biomarker signatures in common carp skin mucus in response to Ichthyophthirius multifiliis.
P2860
Q24301876-D892143A-9A0D-4B35-8897-D57889C27962Q24307916-901305DA-E5C7-409F-BC7D-3251A334BBE1Q27468888-D18DB07C-F026-4E1E-AA26-7A23FEBF78C8Q27488999-E70299D6-F043-47BD-960D-12A4F2897D2DQ28544421-3CAB8104-7FFD-4B52-8E3A-73DDB74E1AE3Q33221677-F1499033-9BCD-49AC-BEE3-F015490469F8Q33347615-0827FAC3-C8E0-4D84-A975-E420735FB1F6Q34157917-8CB2C7A7-982E-470A-B460-92BE44D5E727Q35076765-C9CE3437-BE98-4869-B338-C81E17A48255Q35153497-F1898584-BB9B-42EC-B2BD-7BFDE3C77079Q35635272-F7753909-2C5F-4DDF-9247-CF17E3BC652FQ35833006-9BC84910-4220-46AB-ACD0-8C1B13BEDC80Q36036704-0F65014E-7D03-4E84-B221-212F7879905FQ36618898-1444426B-173A-472E-A860-3FD69C2A25BBQ36627905-F93DE1F5-9932-41E5-A5ED-5B7015DF6A08Q37005470-DA4F5260-553B-44B3-A4C6-A32B29957226Q37672722-CF5A7687-542B-4C93-B107-003DECF14B02Q38212101-4836E9D0-B99F-4F56-9B40-67FD1A5E3494Q38981127-518201B6-0602-45B7-89ED-9D488E060763Q40414692-0AA22E17-D685-4AF4-90C0-461498D134DFQ42978412-85FED548-92E7-405E-ACD5-052A7269B726Q43000770-9BC25CAA-438E-4E11-A26C-FA3E4A9BDC9DQ44490829-36B507B1-C6D8-4D82-9C37-6BA6EA1D00ABQ46820106-17322190-42CA-4AEC-AE6F-6C9DBD3C9A71Q53691077-DD4F590E-BE0E-4282-B996-722B13FFF628
P2860
RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actions
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
RelA-associated inhibitor bloc ...... ting NF-kappaB and Sp1 actions
@ast
RelA-associated inhibitor bloc ...... ting NF-kappaB and Sp1 actions
@en
RelA-associated inhibitor bloc ...... ting NF-kappaB and Sp1 actions
@nl
type
label
RelA-associated inhibitor bloc ...... ting NF-kappaB and Sp1 actions
@ast
RelA-associated inhibitor bloc ...... ting NF-kappaB and Sp1 actions
@en
RelA-associated inhibitor bloc ...... ting NF-kappaB and Sp1 actions
@nl
prefLabel
RelA-associated inhibitor bloc ...... ting NF-kappaB and Sp1 actions
@ast
RelA-associated inhibitor bloc ...... ting NF-kappaB and Sp1 actions
@en
RelA-associated inhibitor bloc ...... ting NF-kappaB and Sp1 actions
@nl
P2093
P2860
P3181
P1433
P1476
RelA-associated inhibitor bloc ...... ting NF-kappaB and Sp1 actions
@en
P2093
Genjiro Kimura
Hiroaki Uranishi
Hiroshi Okamoto
Jian-Ping Yang
Kaori Asamitsu
Lilen Sarol
Norio Takada
Takaomi Sanda
Takashi Okamoto
Toshifumi Tetsuka
P2860
P304
P3181
P356
10.1128/JVI.76.16.8019-8030.2002
P407
P577
2002-08-01T00:00:00Z